Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW.

J Infect Dis. 2000 Feb;181(2):664-70.

PMID:
10669353
2.

Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.

Kurioka T, Yunou Y, Harada H, Kita E.

Eur J Clin Microbiol Infect Dis. 1999 Aug;18(8):561-71.

PMID:
10517193
4.

Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.

Shaikh N, Tarr PI.

J Bacteriol. 2003 Jun;185(12):3596-605. Erratum in: J Bacteriol. 2003 Nov;185(21):6495.

5.

Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.

Mora A, Blanco JE, Blanco M, Alonso MP, Dhabi G, Echeita A, González EA, Bernárdez MI, Blanco J.

Res Microbiol. 2005 Aug;156(7):793-806. Epub 2005 Apr 22.

PMID:
15921895
6.

Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection.

Isogai E, Isogai H, Hayashi S, Kubota T, Kimura K, Fujii N, Ohtani T, Sato K.

Microbiol Immunol. 2000;44(2):89-95.

7.

Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle.

Muniesa M, Blanco JE, De Simón M, Serra-Moreno R, Blanch AR, Jofre J.

Microbiology. 2004 Sep;150(Pt 9):2959-71.

PMID:
15347754
8.

Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.

Rahal EA, Kazzi N, Kanbar A, Abdelnoor AM, Matar GM.

Int J Antimicrob Agents. 2011 Feb;37(2):135-9. doi: 10.1016/j.ijantimicag.2010.10.009. Epub 2010 Dec 3.

PMID:
21129928
9.

Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7.

Loś JM, Loś M, Wegrzyn A, Wegrzyn G.

FEMS Immunol Med Microbiol. 2010 Apr;58(3):322-9. doi: 10.1111/j.1574-695X.2009.00644.x. Epub 2009 Dec 10.

10.

Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.

Oporto B, Esteban JI, Aduriz G, Juste RA, Hurtado A.

Zoonoses Public Health. 2008;55(2):73-81. doi: 10.1111/j.1863-2378.2007.01080.x.

PMID:
18234025
12.
14.

Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.

Ochoa TJ, Chen J, Walker CM, Gonzales E, Cleary TG.

Antimicrob Agents Chemother. 2007 Aug;51(8):2837-41. Epub 2007 May 25.

15.

Serotypes and virulence markers of Shiga toxin-producing Escherichia coli (STEC) isolated from dairy cattle in São Paulo State, Brazil.

Irino K, Kato MA, Vaz TM, Ramos II, Souza MA, Cruz AS, Gomes TA, Vieira MA, Guth BE.

Vet Microbiol. 2005 Jan 5;105(1):29-36. Epub 2004 Dec 10.

PMID:
15607081
16.
17.

Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.

Angel Villegas N, Baronetti J, Albesa I, Etcheverría A, Becerra MC, Padola NL, Paraje MG.

Toxicol In Vitro. 2015 Oct;29(7):1692-700. doi: 10.1016/j.tiv.2015.06.025. Epub 2015 Jun 27.

PMID:
26130220
18.

Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin.

Zangari T, Melton-Celsa AR, Panda A, Smith MA, Tatarov I, De Tolla L, O'Brien AD.

Infect Immun. 2014 Dec;82(12):4968-77. doi: 10.1128/IAI.02361-14. Epub 2014 Sep 15.

19.

Effects of sodium chlorate on toxin production by Escherichia coli O157:H7.

Callaway TR, Anderson RC, Edrington TS, Jung YS, Bischoff KM, Genovese KJ, Poole TL, Harvey RB, Byrd JA, Nisbet DJ.

Curr Issues Intest Microbiol. 2004 Mar;5(1):19-22.

PMID:
15055924

Supplemental Content

Support Center